Winch Advisory Services, LLC Affimed N.V. Transaction History

Winch Advisory Services, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 13, 2018	SELL	$1.45 - $6.15 $725 - $3,075	-500 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$1.65 - $2.5 $825 - $1,250	500 New	500 $1,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Winch Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Winch Advisory Services, LLC with notifications on news.